NSAIDs in COVID-19, friend or foe?
-
Published:2023-01-31
Issue:1
Volume:27
Page:119-122
-
ISSN:2220-5799
-
Container-title:Anaesthesia, Pain & Intensive Care
-
language:
-
Short-container-title:Anaesth. pain intensive care
Author:
Mahrous Reham,Abdelnasser Amr,Fouda Raghda,Moniem Morsy Mohamed Abd Al,Mandour Omnia
Abstract
At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be associated with increased risk of complications of lower respiratory tract infections. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients.
Key words: COVID-19; pandemic; NSAIDs
Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;27(1):119−122; DOI: 10.35975/apic.v27i1.2123
Received: May 29, 2022; Reviewed: June 28, 2022; Accepted: July 03, 2022
Publisher
Aga Khan University Hospital
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine